Skip to Main Content

Tofacitinib for Treatment of Moderate COVID-19 (I-TOMIC)


Diseases of the Respiratory Systems | COVID-19 Inpatient


What is the purpose of this trial?

The purpose of this randomized, double blinded, placebo controlled study is to assess the efficacy and safety of tofacitinib in hospitalized adult (18-65 years old) patients with SARS-CoV-2 and pneumonia who require supplemental oxygen and have serologic markers of inflammation but do not need mechanical ventilation.

  • Trial with
    Yale University School of Medicine
  • Start Date
  • End Date
Trial Image

For more information about this study, contact:

Danielle Peterson

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email or call 877.978.8343

  • Last Updated
  • Study HIC